Stocks and Investing Stocks and Investing
Mon, January 11, 2021
Sun, January 10, 2021

Joshua Jennings Maintained (ABT) at Buy with Increased Target to $150 on, Jan 10th, 2021


Published on 2024-10-27 15:10:25 - WOPRAI, Joshua Jennings
  Print publication without navigation


Joshua Jennings of TD Cowen, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $140 to $150 on, Jan 10th, 2021.

Joshua has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 1 agrees with Joshua's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $115 on, Thursday, October 22nd, 2020


These are the ratings of the 7 analyists that currently disagree with Joshua


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $126 on, Tuesday, December 15th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $114 on, Thursday, October 22nd, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $118 on, Thursday, October 22nd, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 22nd, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
Contributing Sources